Accelerate Diagnostics Inc (AXDX)
0.949
+0.06
(+6.94%)
USD |
NASDAQ |
Apr 23, 16:00
0.939
-0.01
(-1.05%)
After-Hours: 20:00
Accelerate Diagnostics Cash from Financing (TTM): 9.019M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 9.019M |
September 30, 2023 | 8.786M |
June 30, 2023 | 41.64M |
March 31, 2023 | 31.48M |
December 31, 2022 | 31.63M |
September 30, 2022 | 50.65M |
June 30, 2022 | 19.44M |
March 31, 2022 | 31.45M |
December 31, 2021 | 43.23M |
September 30, 2021 | 25.68M |
June 30, 2021 | 27.10M |
March 31, 2021 | 22.06M |
December 31, 2020 | 11.63M |
September 30, 2020 | 10.87M |
June 30, 2020 | 10.24M |
March 31, 2020 | 4.436M |
December 31, 2019 | 6.823M |
September 30, 2019 | 6.417M |
June 30, 2019 | 5.919M |
March 31, 2019 | 27.74M |
December 31, 2018 | 125.77M |
September 30, 2018 | 127.72M |
June 30, 2018 | 127.63M |
March 31, 2018 | 190.24M |
December 31, 2017 | 90.43M |
Date | Value |
---|---|
September 30, 2017 | 89.08M |
June 30, 2017 | 88.78M |
March 31, 2017 | 4.594M |
December 31, 2016 | 1.762M |
September 30, 2016 | 105.37M |
June 30, 2016 | 104.83M |
March 31, 2016 | 103.99M |
December 31, 2015 | 104.82M |
September 30, 2015 | 0.589M |
June 30, 2015 | 0.27M |
March 31, 2015 | 45.00M |
December 31, 2014 | 45.69M |
September 30, 2014 | 45.99M |
June 30, 2014 | 66.38M |
March 31, 2014 | 21.47M |
December 31, 2013 | 40.88M |
September 30, 2013 | 40.52M |
June 30, 2013 | 34.83M |
March 31, 2013 | 34.79M |
October 31, 2012 | 14.52M |
July 31, 2012 | 14.55M |
April 30, 2012 | 0.1944M |
January 31, 2012 | 0.1944M |
October 31, 2011 | |
July 31, 2011 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
4.436M
Minimum
Mar 2020
50.65M
Maximum
Sep 2022
20.97M
Average
19.44M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
Achieve Life Sciences Inc | 15.28M |
ENDRA Life Sciences Inc | 7.518M |
Tivic Health Systems Inc | 8.507M |
Spectral AI Inc | -- |
Perspective Therapeutics Inc | 0.785M |